Reconstitution of the immunological defence and Candida albicans infection in oral mucosa of HIV+ patients under HAART

Authors

  • Marinho Del Santo

DOI:

https://doi.org/10.5935/2525-5711.20160005

Keywords:

candida albicans, HAART, HIV+ patients, immunological defence, oral mucosa

Abstract

The HIV infection is a worldwide spread disease which with the HAART (highly active antiretroviral therapy) application has became a chronicle disease.The HAART promotes the reduction of the HIV viral load and partial and temporary reconstitution of the immunological defence system of the HIV-infected subject, although for that its toxicity and patient adherence to the treatment might be well monitored.With the HAART, the past high prevalence of oral and oropharyngeal lesions decreased significantly, although in a non-homogeneous pattern.The fungus Candida albicans is a commensal microorganism of the human gut tract which provokes an opportunistic infection, when there is an imbalance between its virulence and the defence conditions of the host.The pathogenicity of the Candida albicans influences the degree of opportunistic infection; however, the fungical colonization is mainly dependent of the current immunological status of the patient.The host defence against Candida albicans is also provided by non-immunological barriers, physical as the keratinocytes of the oral epithelium, serological as the neutrophils, polymorphonuclear leukocytes and macrophages or humoral as the saliva, although the role of the salivary immunoglobulins is still unclear. Independently of the immunosuppression, the sensitive control to balance immunological innate and immunological acquired actions is complex and it prevents against an indiscriminate immunological acquired response. Dendritic cells and lymphocytes are the main defensive immunological cells of the oral mucosa. The dendritic cells phagocytise and deplete microorganisms, presenting the products of such depletion as antigens to the T lymphocytes, which provide acquired immunological defence for excellence. Specific Th1 type provides cell-mediated immunological protection against Candida albicans and other pathogens. Moreover, Th2 type cells provide immunological tolerance against external and auto-antigens. Treg and Th17 cells are actors of vital importance in the switching between Th1 type and Th2 type responses, although the complete understanding of their roles in this balance is still an ongoing process.

Author Biography

Marinho Del Santo

DDS, PhD. Orthodontist in Private Practice and Private Lecturer

References

[No authors listed]. Epidemiologic aspects of the current outbreak of Kaposi´s sarcoma and opportunistic infections. N Engl J Med 306:248-252,1982.

[No authors listed]. Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. J Oral Pathol Med 22:289-291,1993.

Abgrall S, Charreau I, Joly V, Bloch J, Reynes J, Delta Coordinating Committee. Risk factors for esophageal candidiasis in a large cohort of HIV-infected patients treated with nucleoside analogues. Eur J Clin Microbiol Infect Dis 20:346-349, 2001. DOI: http://dx.doi. org/10.1007/s100960100497

Acosta-Rodriguez EV, Rivino L, Geginat J et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8:639-646, 2007. PMID: 17486092 DOI: http://dx.doi.org/10.1038/ni1467

Ahlfors EE, Larsson PA, Bergstresser PR. Langerhans cell surfa-ce densities in rat oral mucosa and human buccal mucosa. J Oral Pathol 14:390-397, 1985. PMID: 3159862 DOI: http://dx.doi. org/10.1111/j.1600-0714.1985.tb00510.x

Allan S. Dendritic cells: tailoring T-helper-cell responses. Nat Rev Immun 9:76, 2009.

Ammann AJ and Hong R Selective IgA deficiency: presentation of 30 cases and a review of the literature. Medicine (Baltimore) 50:223-236, 1971. PMID: 4938275

Andersson J, Boasso A, Nilsson J et al. Cutting edge: the prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 174:3143-3147, 2005.

Angel JB, Kumar A, Parato K et al. Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir. J Infect Dis 177:898-904, 1998. PMID: 9534961 DOI: http://dx.doi.org/10.1086/515244

Anjuère F, Martín P, Ferrero I et al. Definition of dendritic cell sub-populations present in the spleen, Peyer´s patches, lymph nodes, and skin of the mouse. Blood 93:590-598, 1999.

Ansel J, Perry P, Brown J et al. Cytokine modulation of keratinocyte cytokines. J Investig Dermatol 94S:101-107, 1990. DOI: http://

dx. doi.org/10.1111/1523-1747.ep12876053

Antinori A, Antinori A, Ammassari A et al. Presumptive clinical criteria versus endoscopy in the diagnosis of Candida esophagitis at various HIV-1 disease stages. Endoscopy 27:371-376, 1995. PMID: 7588351 DOI: http://dx.doi.org/10.1055/s-2007-1005716

Ardavín C. Origin, precursors and differentiation of mouse dendritic cells. Nat Rev Immunol 3:582-590, 2003. PMID: 12876560

Arendorf TM and Walker DM. The prevalence and intra-oral distribu-tion of Candida albicans in man. Arch Oral Biol 25:1-10, 1980. PMID: 6996654 DOI: http://dx.doi.org/10.1016/0003-9969(80)90147-8

Arribas JR, Hernández-Albujar S, González-García JJ et al. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. AIDS 14:979-985, 2000. PMID: 10853979 DOI: http://dx.doi. org/10.1097/00002030-200005260-00009

Ashman RB. Enhancement of MHC class II antigen expression by ex-posure to Candida albicans. Immunol Lett 30:255-260, 1991. PMID: 1757112 DOI: http://dx.doi.org/10.1016/0165-2478(91)90034-8

Ashman RB and Papadimitriou JM. Production and function of cytoki-nes in natural and acquired immunity to Candida albicans infection. Microbiol Rev 59:646-672, 1995. PMID: 8531890

Atkinson JC, Yeh C, Oppenheim FG, Bermudez D, Baum BJ, Fox PC. Elevation of salivary antimicrobial proteins following HIV-1 infection. J Acquir Immune Defic Syndr 3:41-48, 1990. PMID: 2293641

Autran B, Carcelain G, Li TS et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277:112-116, 1997. PMID: 9204894 DOI: http://dx.doi.org/10.1126/science.277.5322.112

Autran B, Carcelain G, Li TS et al. Restoration of the immune system with anti-retroviral therapy. Immunol Lett 66:207-211, 1999. DOI: http://dx.doi.org/10.1016/S0165-2478(98)00159-X

Bachmann MF and Kopf M. Balancing protective immunity and immunopathology. Curr Opin Immunol 14:413-419, 2002. PMID: 12088674 DOI: http://dx.doi.org/10.1016/S0952-7915(02)00363-1

Banchereau J and Steinman RM. Dendritic cells and the control of immunity. Nature 392:245-252, 1998. PMID: 9521319 DOI: http://

dx. doi.org/10.1038/32588

Barchiesi F, Arzeni D, Del Prete MS et al. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis. J Antimicrob Chemother 41:541-548, 1998. PMID: 9630407 DOI: http://dx.doi.org/10.1093/jac/41.5.541

Barrett AW, Cruchley AT, Williams DM. Oral mucosal Langerhans´cells. Crit Rev Oral Biol Med 7:36-58, 1996. PMID: 8727106 DOI: http://

dx. doi.org/10.1177/10454411960070010301

Barron MA, Blyveis N, Palmer BE, MaWhinney S, Wilson CC. Influen-ce of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-in-fected individuals. J Infect Dis 187:26-37, 2003. PMID: 12508143 DOI: http://dx.doi.org/10.1086/345957

Basson NJ and van Wyk CW. The establishment of a community of oral bacteria that controls the growth of Candida albicans in a chemostat. Oral Microbiol Immunol 11:199-202, 1996. DOI: http://dx.doi. org/10.1111/j.1399-302X.1996.tb00358.x

Battegay M, Nüesch R, Hirschel B, Kaufmann GR. Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet In-fect Dis 6:280-287, 2006. PMID: 16631548 DOI: http://dx.doi. org/10.1016/S1473-3099(06)70463-7

Bektic J, Lell CP, Fuchs A et al. HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro. FEMS Immu-nol Med Microbiol 31:65-71, 2001. PMID: 11476984 DOI: http://

dx. doi.org/10.1016/S0928-8244(01)00242-5

Belazi M, Fleva A, Drakoulakos D, Panayiotidou D. Salivary IgA and serum IgA and IgG antibodies to Candida albicans in HIV-infected subjects. Int J STD AIDS 13:373-377, 2002. PMID: 12015010 DOI: http://dx.doi.org/10.1258/095646202760029787

Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 7:875-888, 2007. PMID: 17948021

Belkaid Y and Oldenhove G. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 29:362-371, 2008. PMID: 18799144

Belkaid Y and Rouse BT. Natural regulatory T cells in infectious dise-ase. Nat Immunol 6:353-360, 2005. PMID: 15785761 DOI: http://

dx. doi.org/10.1038/ni1181

Belkaid Y and Tarbell K. Regulatory T cells in the control of host-

- microorganism interactions. Ann Rev Immunol 27:551-589, 2009. DOI: http://dx.doi.org/10.1146/annurev.immunol.021908.132723

Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196:121-135, 1996. DOI: http://dx.doi.org/10.1016/0022-1759(96)00079-8

Beno DW, Stöver AG, Mathews HL. Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes. J Immunol 154:5273-5281, 1995. PMID: 7730631

Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effec-tor T cell trilogy. Curr Opin Immunol 19:652-657, 2007. PMID: 17766098

Bird L. T cells: human Th17 cells take centre stage. Nat Rev Immunol 7:413, 2007.

Blauvelt A, Clerici M, Lucey DR et al. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. J Immunol 154:3506-3515, 1995.

Borg M and Rüchel R. Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect Immun 56:626-631, 1988. PMID: 3277916

Bos IR and Burkhardt A. Interepithelial cells of the oral mucosa. Light and electron microscopic observations in germfree, specific pathogen-free and conventionalized mice. J Oral Pathol 9:65-81, 1980. PMID: 6768863 DOI: http://dx.doi.org/10.1111/j.1600-0714.1980. tb01389.x

Bowers WE and Berkowitz MR. Differentiation of dendritic cells in cultures of rat bone marrow cells. J Exp Med 163:872-883, 1986. PMID: 3512761 DOI: http://dx.doi.org/10.1084/jem.163.4.872

Braathen LR, Ramirez G, Kunze RO, Gelderblom H. Langerhans cells as primary target cells for HIV infection. Lancet 2:1094, 1987. PMID: 2890007 DOI: http://dx.doi.org/10.1016/S0140-6736(87)91526-1

Brambilla AM, Castagna A, Nocita B et al. Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections. J Acquir Immune Syndr 27:44-48, 2001. PMID: 11404519

Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB. Chan-ging incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 11:1731-1738, 1997. PMID: 9386808 DOI: http://dx.doi.org/10.1097/00002030-199714000-00010

Brown GD. Dectin-1: a signalling non-TLR pattern-recognition re-ceptor. Nat Rev Immunol 6:33-43, 2006.

Campo J, Del Romero J, Castilla J, Garcia S, Rodriguez C, Bascones A. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-

- infected patients. J Oral Pathol Med 31:5-10, 2002. PMID: 11896816 DOI: http://dx.doi.org/10.1034/j.1600-0714.2002.310102.x

Cantorna MT and Balish E. Role of CD4+ lymphocytes in resistance to mucosal candidiasis. Infect Immun 59:2447-2455, 1991. PMID: 1675629

Cassone A, de Bernardis F, Torosantucci A, Tacconelli E, Tumbarello M, Cauda R. In vitro and in vivo anticandidal activity of human immuno-deficiency virus protease inhibitors. J Infect Dis 180:448-453, 1999. DOI: http://dx.doi.org/10.1086/314871

Cassone A, Tacconelli E, de Bernardis F et al. Antiretroviral thera-py with protease inhibitors has an early, immune reconstitution-

- independent beneficial effect on Candida virulence and oral candi-diasis in human immunodeficiency virus-infected subjects. J Infect Dis 185:188-195, 2002. PMID: 11807692 DOI: http://dx.doi. org/10.1086/338445

Cauda R, Tacconelli E, Tumbarello M et al. Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infec-tion: a prospective case-control study. J Acquir Immune Defic Syndr 21:20-25, 1999. PMID: 10235510

Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258-261, 1992. PMID: 1279441 DOI: http://

dx. doi.org/10.1038/360258a0

Caux C, Massacrier C, Vanbervliet B et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two indepen-dent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Func-tional analysis. Blood 90:1458-1470, 1997. PMID: 9269763

Caux C, Vanbervliet B, Massacrier C et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two indepen-dent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med 184:695-706, 1996. PMID: 8760823 DOI: http://dx.doi. org/10.1084/jem.184.2.695

Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10-16, 1997. PMID: 9039784 DOI: http://dx.doi.org/10.1016/S0952-7915(97)80153-7

Cilla G, Perez TE, Furundarena JR, Cuadrado E, Iribarren JA, Neira F. Esophageal candidiasis and immunodeficiency associated with acute HIV infection. AIDS 2:399-400, 1988.

Challacombe SJ. Immunologic aspects of oral candidiasis. Oral Surg Oral Med Oral Pathol 78:202-210, 1994. PMID: 7936590 DOI: http://dx.doi.org/10.1016/0030-4220(94)90148-1

Challacombe SJ and Naglik JR. The effects of HIV infection on oral mucosal immunity. Adv Dent Res 19:29-35, 2006. PMID: 16672546 DOI: http://dx.doi.org/10.1177/154407370601900107

Challacombe SJ and Sweet SP. Oral mucosal immunity and HIV in-fection: current status. Oral Dis 8S:55-62, 2002.

Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183:5385-5394, 2001. PMID: 11514524

Chiou CC, Groll AH, Gonzalez CE et al. Esophageal candidiasis in pediatric acquired immunodeficiency syndrome: clinical manifesta-tions and risk factors. Pediatr Infect Dis J 19:729-734, 2000. PMID: 10959741

Chou LL, Epstein J, Cassol AS, West DM, He W, Firth JD. Oral mucosal Langerhans´ cells as target, effector and vector in HIV in-fection. J Oral Pathol Med 29:394-402, 2000. DOI: http://dx.doi. org/10.1034/j.1600-0714.2000.290805.x

Clerici M and Shearer GM A. TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107-111, 1993. PMID: 8096699 DOI: http://dx.doi.org/10.1016/0167-5699(93)90208-3

Colasante A, Rosini S, Piattelli A, Artese L, Aiello FB, Musiani P. Dis-tribution and phenotype of immune cells in normal human gingiva: active immune response versus unresponsiveness. J Oral Pathol Med 21:12-16, 1992. PMID: 1534371

Coleman D, Sullivan D, Harrington B et al. Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infection and AIDS patients. Oral Dis 3S:96-101, 1997.

Conti HR, Shen F, Namrata N et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206:299-311, 2009. DOI: http://dx.doi.org/10.1084/jem.20081463

Coogan MM and Challacombe SJ. Serum and salivary antibodies to a mycobacterial 65-kDa stress protein are elevated in HIV-

- positive patients and modified by oral candidiasis. Oral Microbiol Immunol 15:284-289, 2000. PMID: 11154418 DOI: http://dx.doi. org/10.1034/j.1399-302x.2000.150503.x

Coogan MM, Greenspan JS, Challacombe SJ. Oral lesions in infec-tion with human immunodeficiency virus. Bull World Health Organ 83:700-706, 2005.

Coogan MM, Sweet SP, Challacombe SJ. Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect Immun 62:892-896, 1994. PMID: 8112860

Cruchley AT, Williams DM, Farthing PM, Lesch CA, Squier CA. Regional variation in Langerhans cell distribution and density in normal human oral mucosa determined using monoclonal antibo-dies against CD1, HLADR, HLADQ and HLADP. J Oral Pathol Med 18:510-516, 1989. PMID: 2481737 DOI: http://dx.doi. org/10.1111/j.1600-0714.1989.tb01353.x

Cutler JE. Putative virulence factors of Candida albicans. Annu Rev Microbiol 45:187-218, 1991. PMID: 1741614 DOI: http://dx.doi. org/10.1146/annurev.micro.45.1.187

Cutler CW, Jotwani R, Pulerdran B. Dendritic cells: immune saviors or Achille´s heel? Infec Immun 69:4703-4708, 2001. DOI: http://

dx. doi.org/10.1128/IAI.69.8.4703-4708.2001

Dahl KM, Keath EJ, Fraser VJ, Powderly WG. Molecular epidemiology of mucosal candidiasis in HIV-positive women. AIDS Res Hum Re-troviruses 13:485-491, 1997. PMID: 9100990 DOI: http://dx.doi. org/10.1089/aid.1997.13.485

Daniels TE. Human mucosal Langerhans cells: postmortem identifica-tion of regional variations in oral mucosa. J Invest Dermatol 82:21-24, 1984. PMID: 6228611

Darbyshire J. Therapeutic interventions in HIV infection - a critical view. Trop Med Int Health 5A:26-31, 2000. DOI: http://dx.doi. org/10.1046/j.1365-3156.2000.00597.x

da Silva CA, Dourado I, Dahia SR, Harzheim E, Rutherford GW. Oral manifestations of HIV infection in patients receiving highly ac-tive antiretroviral therapy (HAART) in Bahia, Brazil. J Public Health Dent 68:178-181, 2008. DOI: http://dx.doi.org/10.1111/j.1752-7325.2007.00071.x

de Bernardis F, Chiani P, Ciccozzi M et al. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect Immun 64:466-471, 1996. PMID: 8550193

de Bernardis F, Mühlschlegel FA, Cassone A, Fonzi WA. The pH of the host niche controls gene expression in and virulence of Candida albicans. Infect Immun 66:3317-3325, 1998.

de Bernardis F, Sullivan PA, Cassone A. Aspartyl proteinases of Candida albicans and their role in pathogenicity. Med Mycol 39:303-313, 2001. PMID: 11556759

de Creus A, van Beneden K, Taghon T et al. Langerhans cells that have matured in vivo in the absence of T cells are fully capable of in-ducing a helper CD4 as well as a cytotoxic CD8 response. J Immunol 165:645-653, 2000.

de Repentigny L. Serodiagnosis of candidiasis, aspergillosis, and cryp-tococcosis. Clin Infect Dis 14S:11-22, 1992. DOI: http://dx.doi. org/10.1093/clinids/14.Supplement_1.S11

de Repentigny L, Lewandowski D, Jolicouer P. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus in-fection. Clin Microbiol Rev 17:729-759, 2004. DOI: http://dx.doi. org/10.1128/CMR.17.4.729-759.2004

del Hoyo GM, Mar tín P, Vargas HH, Ruiz S, Arias CF, Ardavín C. Characterization of a common precursor population for dendritic cells. Nature 415:1043-1047, 2002. DOI: http://

dx. doi.org/10.1038/4151043a

Deeks SG, Smith M, Holodniy M, Kahn JO. HIV-1 protease inhibitors. A review for clinicians. JAMA 277:145-153, 1997. PMID: 8990341 DOI: http://dx.doi.org/10.1001/jama.277.2.145

de Repentigny L, Lewandowski D, Jolicoeur P. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infec-tion. Clin Microbiol Rev 17:729-759, 2004. PMID: 15489345 DOI: http://dx.doi.org/10.1128/CMR.17.4.729-759.2004

Desvignes C, Estèves F, Etchart N, Bella C, Czerkinsky C, Kaiserlian D. The murine buccal mucosa is an inductive site for priming class I-res-tricted CD8+ effector T cells in vivo. Clin Exp Immunol 113:386-393, 1998. DOI: http://dx.doi.org/10.1046/j.1365-2249.1998.00671.x

Detels R, Tarwater P, Phair JP et al. Effectiveness of potent antire-troviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. AIDS 15:347-355, 2001. PMID: 11273215 DOI: http://dx.doi.org/10.1097/00002030-200102160-00008

Díaz-Guerra TM, Martínez-Suárez JV, Laguna F, Rodríguez-Tudela JL. Comparison of four molecular typing methods for evaluating genetic diversity among Candida albicans isolates from human immunodefi-ciency virus-positive patients with oral candidiasis. J Clin Microbiol 35:856-861, 1997. PMID: 9157142

Dieleman JP, Jambroes M, Gyssens IC et al. Determinants of recur-rent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA cohort. AIDS 16:737-745, 2002. PMID: 11964530 DOI: http://dx.doi.org/10.1097/00002030-200203290-00009

Diz Dios P, Ocampo A, Miralles C, Otero I, Iglesias I, Rayo N. Fre-quency of oropharyngeal candidiasis in HIV-infected patients on pro-tease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87:437-441, 1999. PMID: 10225625 DOI: http://dx.doi. org/10.1016/S1079-2104(99)70242-8

Diz Dios P, Ocampo A, Otero I, Iglesias I, Martínez C. Changes in oropharyngeal colonization and infection by Candida albicans in human immunodeficiency virus-infected patients. J Infect Dis 183:355-356, 2001. PMID: 11120936

Dodd CL, Greenspan D, Katz MH, Westenhouse JL, Feigal DW, Greenspan JS. Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS. AIDS 5:1339-1343, 1991. PMID: 1768382

Donaghy H, Pozniak A, Gazzard B et al. Loss of blood CD11c+ mye-loid and CD11c- plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 98:2574-2576, 2001. PMID: 11588058 DOI: http://dx.doi.org/10.1182/blood. V98.8.2574

Dong C. Th17 cells in development: an updated view of their molecu-lar identity and genetic programming. Nat Rev Immunol 8:337-348, 2008. PMID: 18408735

Dongari-Bagtzoglou A and Fidel PL Jr. The host cytokine respon-ses and protective immunity in oropharyngeal candidiasis. J Dent Res 84:966-977, 2005. PMID: 16246925 DOI: http://dx.doi. org/10.1177/154405910508401101

Dongari-Bagtzoglou A and Kashleva H. Granulocyte-macrophage co-lony-stimulating factor responses of oral epithelial cells to Candida al-bicans. Oral Microbiol Immunol 18:165-170, 2003. PMID: 12753468 DOI: http://dx.doi.org/10.1034/j.1399-302X.2003.00061.x

Dongari-Bagtzoglou A, Kashleva H, Villar CC. Bioactive interleukin-1 alpha is cytolytically released from Candida albicans-infected oral epithelial cells. Med Mycol 42:531-541, 2004. PMID: 15682642

Dorhoi A and Kaufmann SH. Fine-tuning of T cell responses during infection. Curr Opin Immunol 21:367-377, 2009. PMID: 19646852 DOI: http://dx.doi.org/10.1016/j.coi.2009.07.004

d´Ostiani CF, Del Sero G, Bacci A et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 191:1661-1674, 2000.

Drobacheff C, Millon L, Monod M et al. Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis. Clin Chem Lab Med 39:519-526, 2001. PMID: 11506465 DOI: http://dx.doi.org/10.1515/CCLM.2001.087

Edgerton M, Koshlukova SE, Lo TE, Chrzan BG, Straubinger RM, Raj PA. Candidacidal activity of salivary histatins. Identification of a his-tatin 5-binding protein on Candida albicans. J Biol Chem 273:20438-20447, 1998. DOI: http://dx.doi.org/10.1074/jbc.273.32.20438

Edgerton M, Scannapieco FA, Reddy MS, Levine MJ. Human submandibular-sublingual saliva promotes adhesion of Candida albi-cans to polymethylmethacrylate. Infect Immun 61:2644-2652, 1993. PMID: 8500903

Elahi S, Pang G, Clancy R, Ashman RB. Cellular and cytokine corre-lates of mucosal protection in murine model of oral candidiasis. Infect Immun 68:5771-5777, 2000. PMID: 10992484 DOI: http://dx.doi. org/10.1128/IAI.68.10.5771-5777.2000

Epstein JB, Kimura LH, Menard TW, Truelove EL, Pearsall NN. Effects of specific antibodies on the interaction between the fungus Candida albicans and human oral mucosa. Arch Oral Biol 27:469-474, 1982. PMID: 6956259 DOI: http://dx.doi.org/10.1016/0003-9969(82)90086-3

Eversole LR, Reichart PA, Ficarra G, Schmidt-Westhausen A, Romagnoli P, Pimpinelli N. Oral keratinocyte immune responses in HIV-associated candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84:372-380, 1997. PMID: 9347501 DOI: http://

dx. doi.org/10.1016/S1079-2104(97)90035-4

Farah CS, Elahi S, Drysdale K et al. Primary role for CD4+ T lymphocytes in recovery from oropharyngeal candidiasis. Infect Immun 70:724-731, 2002. PMID: 11796605 DOI: http://dx.doi. org/10.1128/IAI.70.2.724-731.2002

Farah CS, Elahi S, Pang G et al. T cells augment monocyte and neu-trophil function in host resistance against oropharyngeal candidiasis. Infect Immun 69:6110-6118, 2001. PMID: 11553549 DOI: http://

dx. doi.org/10.1128/IAI.69.10.6110-6118.2001

Farah CS, Gotjamanos T, Seymour GJ, Ashman RB. Cytokines in the oral mucosa of mice infected with Candida albicans. Oral Microbiol Immunol 17:375-378, 2002. PMID: 12485329 DOI: http://dx.doi. org/10.1034/j.1399-302X.2002.170607.x

Feigal DW, Katz MH, Greenspan D et al. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 5:519-525, 1991. PMID: 1863403

Ferreira S, Noce C, Junior AS et al. Prevalence of oral manifestations of HIV infection in Rio de Janeiro, Brazil from 1988 to 2004. AIDS Patient Care STDS 21:724-731, 2007. PMID: 17949271 DOI: http://

dx. doi.org/10.1089/apc.2006.0211

Fichtenbaum CJ, Koletar S, Yiannoutsos C et al. Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. Clin Infect Dis 30:749-756, 2000. PMID: 10816143 DOI: http://dx.doi. org/10.1086/313765

Fidel PL Jr. Distinct protective host defenses against oral and vaginal candidiasis. Med Mycol 40:359-375, 2002. PMID: 12230215

Fidel PL Jr. Immunity to Candida. Oral Dis 8S:69-75, 2002. DOI: http://dx.doi.org/10.1034/j.1601-0825.2002.00015.x

Fidel PL Jr. and Sobel JD. Immunopathogenesis of recurrent vul-vovaginal candidiasis. Clin Microbiol Rev 9:335-348, 1996. PMID: 8809464

Fidel PL Jr., Vazquez JA, Sobel JD. Candida glabata: review of epi-demiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 12:80-96, 1999.

Fidel PL Jr., Wolf NA, KuKuruga MA. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect Immun 64:3793-3799, 1996. PMID: 8751931

Fong IW, Laurel M, Burford-Mason A. Asymptomatic oral carriage of Candida albicans in patients with HIV infection. Clin Investig Med 20:85-93, 1997.

Formanek M, Knerer B, Kornfehl J. Cytokine expression of human oral keratinocytes. ORL J Otorhinolaryngol Relat Spec 61:103-107, 1999. PMID: 10095201 DOI: http://dx.doi. org/10.1159/000027650

Frankel SS, Tenner-Racz K, Racz P et al. Active replication of HIV-1 at the lymphoepithelial surface of the tonsil. Am J Pathol 151:89-96, 1997. PMID: 9212735

Frankel SS, Wenig BM, Burke AP et al. Replication of the HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 272:115-117, 1996. PMID: 8600520 DOI: http://dx.doi. org/10.1126/science.272.5258.115

Gillespie GM and Mariño R. Oral manifestations of HIV infection: a Panamerican perspective. J Oral Pathol Med 22:2-7, 1993.

Gilliet M and Liu YJ. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195:695-704, 2002. PMID: 11901196 DOI: http://dx.doi. org/10.1084/jem.20011603

Giuliani M, Lajolo C, Sartorio A et al. Oral lesions in HIV and HCV co-infected individuals in HAART era. J Oral Pathol Med 37:468-474, 2008. PMID: 18298476 DOI: http://dx.doi.org/10.1111/j.1600-0714.2008.00647.x

Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13:122-143, 2000. PMID: 10627494 DOI: http://dx.doi.org/10.1128/CMR.13.1.122-143.2000

Glick M, Muzyka BC, Lurie D, Salkin LM. Oral manifestations as-sociated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 77:344-349, 1994. PMID: 8015797 DOI: http://dx.doi.org/10.1016/0030-4220(94)90195-3

Goupil M, Trudelle EB, Dugas V et al. Macrophage-mediated res-ponses to Candida albicans in mice expressing the human immunode-ficiency virus type 1 transgene. Infect Immunol 77:4136-4149, 2009. DOI: http://dx.doi.org/10.1128/IAI.00453-09

Gottlieb MS, Schroff R, Schanker HM et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 305:1425-1431, 1981.

Grassi F, Hosmalin A, McIlroy D, Calvez V, Debré P, Autran B. De-pletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS 13:759-766, 1999. PMID: 10357374 DOI: http://

dx. doi.org/10.1097/00002030-199905070-00004

Greenspan JS, Barr CE, Sciubba JJ, Winkler JR. Oral manifestations of HIV infection. Definitions, diagnostic criteria, and principles of thera-py. The USA Oral AIDS Collaborative Group. Oral Surg Oral Med Oral Pathol 73:142-144, 1992. DOI: http://dx.doi.org/10.1016/00304220(92)90185-S

Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 357:1411-1412, 2001. PMID: 11356441 DOI: http://dx.doi. org/10.1016/S0140-6736(00)04578-5

Greenspan D and Greenspan JS. Oral manifestations of human immunodeficiency virus infection. Dent Clin North Am 37:21-32, 1993. PMID: 8416823

Greenspan D and Greenspan JS. HIV-related oral disease. Lan-cet 348:729-733, 1996. PMID: 8806295 DOI: http://dx.doi. org/10.1016/S0140-6736(96)02308-2

Greenspan D, Greenspan JS, Conant M, Petersen V, Silverman S Jr., de Souza Y. Oral “hairy” leucoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus. Lancet 2:831-834, 1984. PMID: 6148571

Greenspan D, Komaroff E, Redford M et al. Oral mucosal lesions and HIV viral load in the Women’s Interagency HIV Study (WIHS). J Acquir Immune Defic Syndr 25:44-50, 2000. PMID: 11064503 DOI: http://dx.doi.org/10.1097/00126334-200009010-00006

Gringhuis SI, den Dunnen J, Litjens M et al. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-KB activa-tion through Raf-1 and Syk. Nat Immunol 10:203-213, 2009. PMID: 19122653 DOI: http://dx.doi.org/10.1038/ni.1692

Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 185:1101-1111, 1997. PMID: 9091583

Gruber A, Lukasser-Vogl E, Borg-von Zepelin M, Dierich MP, Würzner R. Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro. J Infect Dis 177:1057-1063, 1998. PMID: 9534982 DOI: http://dx.doi.org/10.1086/515231

Hacker MA, Kaida A, Hogg RS, Bastos FI. The first ten years: achie-vements and challenges of the Brazilian program of universal access to HIV/AIDS comprehensive management and care, 1996-2006. Cad Saude Publica 23S:345-359, 2007.

Hasséus B, Jontell M, Bergenholtz G, Eklund C, Dahlgren UI. Lan-gerhans cells from oral epithelium are more effective in stimulating allogeneic T-cells in vitro than Langerhans cells from skin epithelium. J Dent Res 78:751-758, 1999. PMID: 10096450

Helmerhorst EJ, Flora B, Troxler RF, Oppenheim FG. Dialysis un-masks the fungicidal properties of glandular salivary secretions. Infect Immun 72:2703-2709, 2004. PMID: 15102779 DOI: http://dx.doi. org/10.1128/IAI.72.5.2703-2709.2004

Hibino K, Samaranayake LP, Hägg U, Wong RWK, Lee W. The role of salivary factors in persistent oral carriage of Candida in humans. Arch Oral Biol 54:678-683, 2009. DOI: http://dx.doi.org/10.1016/j. archoralbio.2009.04.003

Hill IR and Porter P. Studies of bactericidal activity to Escherichia coli of porcine serum and colostral immunoglobulins and the role of lysozyme with secretory IgA. Immunology 26:1239-1250, 1974.

Hodgson TA, Greenspan D, Greenspan JS. Oral lesions of HIV disease and HAART in industrialized countries. Adv Dent Res 19:57-62, 2006. PMID: 16672551 DOI: http://dx.doi. org/10.1177/154407370601900112

Hoffman MP and Haidaris CG. Analysis of Candida albicans adhesion to salivary mucin. Infect Immun 61:1940-1949, 1993. PMID: 8478083

Hogue IB, Bajaria SH, Fallert BA, Qin S, Reinhart TA, Kirschner DE. The dual role of dendritic cells in the immune response to human immunodeficiency virus type 1 infection. J Gen Virol 89:2228-2239, 2008. PMID: 18753232 DOI: http://dx.doi.org/10.1099/vir.0.83600-0

Hohl TM, Rivera A, Palmer EG. Immunity to fungi. Curr Opin Immunol 18:465-472, 2006. DOI: http://dx.doi.org/10.1016/j. coi.2006.05.003

Holmberg K and Meyer RD. Fungal infections in patients with AIDS and AIDS-related complex. Scand J Infect Dis 18:179-192, 1986. PMID: 3526530 DOI: http://dx.doi.org/10.3109/00365548609032326

Howcroft TK, Strebel K, Martin MA, Singer DS. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Scien-ce 260:1320-1322, 1993. PMID: 8493575 DOI: http://dx.doi. org/10.1126/science.8493575

Hube B. Candida albicans secreted aspartyl proteinases. Curr Top Med Mycol 7:55-69, 1996. PMID: 9504059

Hube B, Monod M, Schofield DA, Brown AJ, Gow NA. Expression of seven members of the gene family encoding secretory aspartyl pro-teinases in Candida albicans. Mol Microbiol 14:87-99, 1994. PMID: 7830564 DOI: http://dx.doi.org/10.1111/j.1365-2958.1994. tb01269.x

Hussain LA and Lehner T. Comparative investigation of Langerhans’ cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology 85:475-484, 1995. PMID: 7558138

Ibrahim AS, Mirbod F, Filler SG et al. Evidence implicating phos-pholipase as a virulence factor of Candida albicans. Infect Immun 63:1993-1998, 1995. PMID: 7729913

Ives NJ, Gazzard BG, Easterbrook PJ. The changing pattern of AIDS-

- defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. J Infect 42:134-139, 2001. DOI: http://dx.doi.org/10.1053/jinf.2001.0810

Iwazaki A. Mucosal dendritic cells. Annu Rev Immunol 25:381-418, 2007.

Janeway CA, Jr. The immune system evolved to discriminate infec-tious nonself from infectious self. Immunol Today 13:11-16, 1992. DOI: http://dx.doi.org/10.1016/0167-5699(92)90198-G

Jones-Carson J, Vásquez-Torres A, van der Heyde HC, Warner T, Wagner RD, Balish E. Gamma delta T cell-induced nitric oxide produc-tion enhances resistance to mucosal candidiasis. Nat Med 1:552-557, 1995. DOI: http://dx.doi.org/10.1038/nm0695-552

Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of inter-leukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192:1213-1222, 2000. PMID: 11067871 DOI: http://dx.doi.org/10.1084/jem.192.9.1213

Jotwani R and Cutler CW. Multiple dendritic cell (DC) subpopula-tions in human gingiva and association of mature dendritic cells with CD4+ T-cells in situ. J Dent Res 82:736-741, 2003. DOI: http://

dx. doi.org/10.1177/154405910308200915

Jotwani R, Palucka AK, Al Quotub M et al. Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies. J Immunol 167:4693-4700, 2001.

Kalinski P and Moser M. Consensual immunity: success-driven de-velopment of T-helper-1 and T-helper-2 responses. Nat Rev Immunol 5:252-260, 2005.

Kaplan JE, Hanson D, Dworkin MS et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 30S:5-14, 2000. DOI: http://dx.doi.org/10.1086/313843

Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3:984-993, 2003. PMID: 14647480 DOI: http://dx.doi.org/10.1038/nri1246

Katz MH, Greenspan D, Westenhouse J et al. Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS 6:95-100, 1992. PMID: 1543572 DOI: http://

dx. doi.org/10.1097/00002030-199201000-00013

Kirby AJ, Muñoz A, Detels R, Armstrong JA, Saah A, Phair JP. Thrush and fever as measures of immunocompetence in HIV-1-infected men. J Acquir Immune Defic Syndr 7:1242-1249, 1994. DOI: http://dx.doi. org/10.1097/00126334-199412000-00005

Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 311:354-358, 1984. PMID: 6738653 DOI: http://dx.doi.org/10.1056/NEJM198408093110602

Klinkerk WE. Rat bone marrow precursors develop into dendritic accessory cells under the influence of a conditioned medium. Immu-nobiology 168:414-424, 1984.

Kolokotronis A, Kioses V, Antoniades D, Mandraveli K, Doutsos I, Papanayotou P. Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia. Oral Surg Oral Med Oral Pathol 78:41-46, 1994. PMID: 8078662 DOI: http://dx.doi. org/10.1016/0030-4220(94)90115-5

Kopp E and Medzhitov R. Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol 15:396-401, 2003. PMID: 12900270 DOI: http://dx.doi.org/10.1016/S0952-7915(03)00080-3

Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 27:485-517, 2009. PMID: 19132915 DOI: http://

dx. doi.org/10.1146/annurev.immunol.021908.132710

Kunkl A, Mortara L, Valle MT et al. Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons. J Infect Dis 178:488-496, 1998. DOI: http://

dx. doi.org/10.1086/515620

Lasker BA, Elie CM, Lott TJ et al. Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits. Med Mycol 39:341-352, 2001. PMID: 11556764 DOI: http://dx.doi.org/10.1080/714031035

Launay O, Lortholary O, Bouges-Michel C, Jarrousse B, Bentata M, Guillevin L. Candidemia: a nosocomial complication in adults with late-stage AIDS. Clin Infect Dis 26:1134-1141, 1998. PMID: 9597242

Ledergerber B, Egger M, Telenti A. AIDS-related opportunistic ill-ness and potent antiretroviral therapy. JAMA 283:2653-2654, 2000. PMID: 10819936

LeibundGut-Landmann S, Grob O, Robinson J et al. Syk- and CARD-9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8:630-638, 2007. DOI: http://dx.doi.org/10.1038/ni1460

Leigh JE, Barousse M, Swoboda RK et al. Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis. J Infect Dis 183:277-285, 2001. PMID: 11120933 DOI: http://dx.doi.org/10.1086/317944

Leigh JE, Steele C, Wormley FL, Jr. et al. Th1/Th2 cytokine expres­sion in saliva of HIV-positive and HIV-negative individuals: a pilot studyin HIV-positive individuals with oropharyngeal candidiasis. J AcquirImmune Defic Syndr Hum Retrovirol 19:373-380, 1998.

Lenander-Lumikari M and Johansson I. Effect of saliva composition on growth of Candida albicans and Torulopsis glabata. Oral Microbiol Immunol 10:233-240, 1995. DOI: http://dx.doi.org/10.1111/j.1399-302X.1995.tb00148.x

Levitz SM. Interactions of toll-like receptors with fungi. MicrobesInfect 6:1351-1355, 2004. PMID: 15596119 DOI: http://dx.doi.org/10.1016/j.micinf.2004.08.014

Levitz SM, Mathews HL, Murphy JW. Direct antimicrobial activityof T cells. Immunol Today 16:387-391, 1995. PMID: 7546195 DOI: http://dx.doi.org/10.1016/0167-5699(95)80007-7

Li J, Farthing PM, Thornhill MH. Cytokine regulation of major his­tocompatibility complex antigen expression by human oral and skinkeratinocytes. Arch Oral Biol 41:533-538, 1996. PMID: 8937643DOI: http://dx.doi.org/10.1016/0003-9969(96)00026-X

Liew FY, Xu D, Brint EK. Negative regulation of Toll-like receptor­-mediated immune responses. Nat Rev Immunol 5:446-458, 2005.PMID: 15928677 DOI: http://dx.doi.org/10.1038/nri1630

Lifson AR, Hilton JF, Westenhouse JL et al. Time from HIV serocon­version to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 8:73-79,1994. PMID: 8011239 DOI: http://dx.doi.org/10.1097/00002030-199401000-00011

Lilly EA, Hart DJ, Leigh JE et al. Tissue-associated cytokine expres­sion in HIV-positive persons with oropharyngeal candidiasis. J InfectDis 190:605-612, 2004. PMID: 15243938 DOI: http://dx.doi.org/10.1086/422154

Lin AL, Johnson DA, Patterson TF et al. Salivary anticandidal activity and saliva composition in an HIV-infected cohort. Oral Microbiol Im­munol 16:270-278, 2001. DOI: http://dx.doi.org/10.1034/j.1399-302x.2001.016005270.x

Liu YJ, Kanzler H, Soumelis V, Gilliet M. Dendritic cell lineage,plasticity and cross-regulation. Nature Immunol 2:585-589, 2001.DOI: http://dx.doi.org/10.1038/89726

Lombardi T, Hauser C, Budtz-Jörgensen E. Langerhans cells: struc­ture, function and role in oral pathological conditions. J Oral PatholMed 22:193-202, 1993. PMID: 8315598

Lopez-Dupla M, Mora Sanz P, Pintado G et al. Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esopha­geal candidiasis in HIV-infected patients: a survey of 114 cases. Am JGastroenterol 87:1771-1776, 1992.

Lu L, Hsieh M, Oriss TB et al. Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and func­tional analysis. Immunology 84:127-134, 1995.

Lundqvist C, Baranov V, Teglund S, Hammarström S, Hammarström ML. Cytokine profile and ultrastructure of intraepithelial gamma delta Tcells in chronically inflamed human gingiva suggest a cytotoxic effector function. J Immunol 153:2302-2312, 1994. PMID: 8051426

Lupetti A, Guzzi G, Paladini A, Swart K, Campa M, Senesi S.Molecular typing of Candida albicans in oral candidiasis: karyotypeepidemiology with human immunodeficiency virus-seropositive pa­tients in comparison with that with healthy carriers. J Clin Microbiol 33:1238-1242, 1995. PMID: 7615734

Ma CS, Chew GYJ, Simpson N et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 205:1551-1557, 2008. DOI: http://dx.doi.org/10.1084/jem.20080218

Macatonia SE, Lau R, Patterson S, Pinching AJ, Knight SC. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 71:38-45, 1990. PMID: 2145214

MacDonald AS and Pearce EJ. Cutting edge: polarized Th cellresponse induction by transferred antigen-pulsed dendritic cells isdependent on IL-4 or IL-12 production by recipient cells. J Immunol 168:3127-3130, 2002. PMID: 11907061

Maenza JR, Merz WG, Romagnoli MJ, Keruly JC, Moore RD,Gallant JE. Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology. Clin Infect Dis 24:28-34,1997. PMID: 8994752

Makala LH and Nagasawa H. Dendritic cells: a specialized complexsystem of antigen presenting cells. J Vet Med Sci 64:181-193, 2002. PMID: 11999435

Mandel ID, Barr CE, Turgeon L. Longitudinal study of parotid saliva in HIV-1 infection. J Oral Pathol Med 21:209-213, 1992. PMID:1403836 DOI: http://dx.doi.org/10.1111/j.1600-0714.1992.tb00103.x

Marcotte H and Lavoie MC. Oral microbial ecology and the roleof salivary immunoglobulin A. Microbiol Mol Biol Rev 62:71-109,1998. PMID: 9529888

Margiotta V, Campisi G, Mancuso S, Accurso V, Abbadessa V. HIVinfection: oral lesions, CD4+ cell count and viral load in an Italianstudy population. J Oral Pathol Med 28:173-177, 1999.

Martinez FO, Helming L, Gordon S. Alternative activation of ma­crophages: an immunologic functional perspective. Ann Rev Immunol 27:451-483, 2009.

Martins MD, Lozano-Chiu M, Rex JH. Declining rates of oropha­ryngeal candidiasis and carriage of Candida albicans associated withtrends toward reduced rates of carriage of fluconazole-resistant C.albicans in human immunodeficiency virus-infected patients. ClinInfect Dis 27:1291-1294, 1998. PMID: 9827284 DOI: http://dx.doi.org/10.1086/515006

McCarthy GM. Host factors associated with HIV-related oral candidia­sis. A review. Oral Surg Oral Med Oral Pathol 73:181-186, 1992. PMID: 1532236 DOI: http://dx.doi.org/10.1016/0030-4220(92)90192-S

McCarthy GM, Mackie ID, Koval J, Sandhu HS, Daley TD. Factorsassociated with increased frequency of HIV-related oral candidiasis. J Oral Pathol Med 20:332-336, 1991. PMID: 1680189 DOI: http://dx.doi.org/10.1111/j.1600-0714.1991.tb00940.x

McGuirk P and Mills KHG. Pathogen-specific regulatory T cellsprovoke a shift in the Th1/Th2 paradigm in immunity to infectiousdiseases. Trends Immunol 23:450-455, 2002. DOI: http://dx.doi.org/10.1016/S1471-4906(02)02288-3

McIlroy D, Autran B, Clauvel JP, Oksenhendler E, Debré P, Hosmalin A. Low CD83, but normal MHC class II and costimulatory moleculeexpression, on spleen dendritic cells from HIV+ patients. AIDS ResHum Retroviruses 14:505-513, 1998. PMID: 9566553

Medzhitov R. Recognition of microorganisms and activation of theimmune response. Nature 449:819-826, 2007. PMID: 17943118DOI: http://dx.doi.org/10.1038/nature06246

Medzhitov R and Janeway CA, Jr. Advances in Immunology: innateimmunity. New Engl J Med 343:338-344, 2000.

Meiller TF, Jabra-Rizk MA, Baqui A et al. Oral Candida dubli­niensis as a clinically important specie in HIV-seropositive patientsin the United States. Oral Surg Oral Med Oral Pathol Oral RadiolEndod 88:573-580, 1999. DOI: http://dx.doi.org/10.1016/S1079-2104(99)70088-0

Melo NR, Taguchi H, Culhari VP et al. Oral candidiasis of HIV­-infected children undergoing sequential HIV therapies. MedMycol 47:149-156, 2009. PMID: 18651304 DOI: http://dx.doi.org/10.1080/13693780802195315

Mencacci A, Del Sero G, Cenci E et al. Endogenous interleukin 4is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans. J Exp Med 187:307-317, 1998. PMID: 9449711 DOI: http://dx.doi.org/10.1084/jem.187.3.307

Mezzaroma I, Carlesimo M, Pinter E et al. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS 13:1187-1193, 1999. PMID: 10416521 DOI: http://dx.doi.org/10.1097/00002030-199907090-00006

Mills KHG. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4:841-855, 2004. PMID: 15516964 DOI: http://dx.doi.org/10.1038/nri1485

Miziara ID and Weber R. Oral lesions as predictors of highly activeantiretroviral therapy failure in Brazilian HIV-infected children. J Oral Pathol Med 37:99-106, 2008. DOI: http://dx.doi.org/10.1111/j.1600-0714.2007.00598.x

Mohamed AM. Ultrastructural aspects of chronic oral candidosis. JOral Pathol 4:180-194, 1975. PMID: 811778 DOI: http://dx.doi.org/10.1111/j.1600-0714.1975.tb01741.x

Monod M, Hube B, Hess D, Sanglard D. Differential regulationof SAP8 and SAP9, which encode two new members of the secre­ted aspartic proteinase family in Candida albicans. Microbiology144:2731-2737, 1998. PMID: 9802014 DOI: http://dx.doi.org/10.1099/00221287-144-10-2731

Mostefaoui Y, Claveau I, Rouabhia M. In vitro analyses of tissuestructure and interleukin-1beta expression and production byhuman oral mucosa in response to Candida albicans infections.Cytokine 25:162-171, 2004. PMID: 15162833 DOI: http://dx.doi.org/10.1016/j.cyto.2003.11.015

Müller F, Froland SS, Hvatum M, Radl J, Brandtzaeg P. Both IgAsubclasses are reduced in parotid saliva from patients with AIDS. Clin Exp Immunol 83:203-209, 1991. PMID: 1899629

Munro CA and Hube B. Anti-fungal therapy at the HAART of viraltherapy. Trends Microbiol 10:173-177, 2002. PMID: 11912023

Myers TA, Leigh JE, Arribas AR et al. Immunohistochemicalevaluation of T cells in oral lesions from human immunodeficiencyvirus-positive persons with oropharyngeal candidiasis. Infect Im­mun 71:956-963, 2003. PMID: 12540578 DOI: http://dx.doi.org/10.1128/IAI.71.2.956-963.2003

Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18regulates both Th1 and Th2 responses. Ann Rev Immunol 19:423-474, 2001. DOI: http://dx.doi.org/10.1146/annurev.immunol.19.1.423

Netea MG, Gijzen L, Coolen N et al. Human dendritic cells areless potent at killing Candida albicans than both monocytes and ma­crophages. Microbes Infect 6:985-989, 2004. DOI: http://dx.doi.org/10.1016/j.micinf.2004.05.013

Netea MG, van der Graaf C, van der Meer JW, Kullberg BJ. Toll-like receptors and the host defense against microbial pathogens: bringingspecificity to the innate-immune system. J Leukoc Biol 75:749-755, 2004. PMID: 15075354

Newman SL and Holly A. Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells. Infect Immun 69:6813-6822, 2001. PMID: 11598054 DOI: http://dx.doi.org/10.1128/IAI.69.11.6813-6822.2001

Nielsen H, Bentsen KD, Hojtved L et al. Oral candidia­sis and immune status of HIV-infected patients. J Oral PatholMed 23:140-143, 1994. PMID: 7912732 DOI: http://dx.doi.org/10.1111/j.1600-0714.1994.tb01102.x

Nikawa H, Samaranayake LP, Tenovuo J, Pang KM, Hamada T. Thefungicidal effect of human lactoferrin on Candida albicans and Can­dida krusei. Arch Oral Biol 38:1057-1063, 1993. PMID: 8141667DOI: http://dx.doi.org/10.1016/0003-9969(93)90167-K

Nilsson J, Boasso A, Velilla PA et al. HIV-1-driven regulatory T-cellaccumulation in lymphoid tissues is associated with disease progres­sion in HIV/AIDS. Blood 108:3808-3817, 2006. PMID: 16902147DOI: http://dx.doi.org/10.1182/blood-2006-05-021576

Nottet HS, de Graaf L, de Vos NM et al. Phagocytic function ofmonocyte- derived macrophages is not affected by human immu­nodeficiency virus type 1 infection. J Infect Dis 168:84-91, 1993.DOI: http://dx.doi.org/10.1093/infdis/168.1.84

O´Brien WA. Resistance against reverse transcriptase inhibitors. Clin Infec Dis 30S:185-192, 2000.

Odden K, Schenck K, Hurlen B. High numbers of T cells in gingivafrom patients with human immunodeficiency virus (HIV) infection.J Oral Pathol Med 24:413-419, 1995. PMID: 8537915 DOI: http://dx.doi.org/10.1111/j.1600-0714.1995.tb01211.x

Ollert MW, Wende C, Görlich M et al. Increased expression ofCandida albicans secretory proteinase, a putative virulence factor, inisolates from human immunodeficiency virus-positive patients. J Clin Microbiol 33:2543-2549, 1995. PMID: 8567880

Ortega KL, Ceballos-Salobreña A, Gaitán-Cepeda LA, Magalhães MG. Oral manifestations after immune reconstitution in HIV patientson HAART. Int J STD AIDS 19:305-308, 2008. PMID: 18482959DOI: http://dx.doi.org/10.1258/ijsa.2007.007261

Pacanowsky J, Kahi S, Baillet M et al. Reduced blood CD123+(lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 98:3016-3021, 2001.

Palella FJ Jr., Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodefi­ciency virus infection. HIV Outpatient Study Investigators. N EnglJ Med 338:853-860, 1998. DOI: http://dx.doi.org/10.1056/NEJM199803263381301

Pakker NG, Roos MT, van Leeuwen R et al. Patterns of T-cell re­population, virus load reduction, and restoration of T-cell functionin HIV-infected persons during therapy with different antiretroviralagents. J Acquir Immune Defic Syndr Hum Retrovirol 16:318-326,1997. PMID: 9420308 DOI: http://dx.doi.org/10.1097/00042560-199712150-00002

Palmer GD, Robinson PG, Challacombe SJ et al. Aetiological factors for oral manifestations of HIV. Oral Dis 2:193-197, 1996. PMID:9081758 DOI: http://dx.doi.org/10.1111/j.1601-0825.1996.tb00223.x

Patterson S, English NR, Longhurst H et al. Analysis of human im­munodeficiency virus type 1 (HIV-1) variants and levels of infectionin dendritic and T cells from symptomatic HIV-1 infected patients. JGen Virol 79:247-257, 1998. PMID: 9472609

Patton LL. Sensitivity, specificity, and positive predictive value oforal opportunistic infections in adults with HIV/AIDS as markersof immune suppression and viral burden. Oral Surg Oral Med OralPathol Oral Radiol Endod 90:182-188, 2000. PMID: 10936837DOI: http://dx.doi.org/10.1067/moe.2000.108799

Patton LL, McKaig RG, Strauss RP, Eron JJ. Jr. Oral manifestationsof HIV in a southeast USA population. Oral Dis 4:164-169, 1998.DOI: http://dx.doi.org/10.1111/j.1601-0825.1998.tb00274.x

Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ, Jr. Changingprevalence of oral manifestations of human immunodeficiency virusin the era of protease inhibitor therapy. Oral Surg Oral Med OralPathol Oral Radiol Endod 89:299-304, 2000. DOI: http://dx.doi.org/10.1016/S1079-2104(00)70092-8

Peiser M, Grützkau A, Wanner R, Kolde G. CD1a and CD1c cellsorting yields a homogeneous population of immature human Lan­gerhans cells. J Immunol Methods 279:41-53, 2003. PMID: 12969546 DOI: http://dx.doi.org/10.1016/S0022-1759(03)00257-6

Peña JM, Martinez-Lopez MA, Arnalich F, Barbado FJ, Vazquez JJ.Esophageal candidiasis associated with acute infection due to humanimmunodeficiency virus: case report and review. Rev Infect Dis13:872-875, 1991. PMID: 1962101

Petrosillo N, Viale P, Nicastri E et al. Nosocomial bloodstreaminfections among human immunodeficiency virus-infected patients:incidence and risk factors. Clin Infect Dis 34:677-685, 2002.PMID: 11823956

Pillay D, Taylor S, Richman DD. Incidence and impact of resistanceagainst approved antiretroviral drugs. Rev Med Virol 10:231-253,2000. PMID: 10891871 DOI: http://dx.doi.org/10.1002/1099­-1654(200007/08)10:4<231::AID-RMV290>3.0.CO;2-P

Polyak S, Chen H, Hirsch D, George I, Hershberg R, Sperber K.Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection. J Immunol 159:2177-2188, 1997. PMID: 9278305

Pomarico L, Cerqueira DF, Soares RMA et al. Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108:203-210, 2009. DOI: http://dx.doi.org/10.1016/j.tripleo.2009.05.008

Pope M. Mucosal dendritic cells and immunodeficiency vi­ruses. J Infect Dis 179:S427-430, 1999. DOI: http://dx.doi.org/10.1086/314798

Pope M, Elmore D, Ho D, Marx P. Dendritic cell-T cell mixtures,isolated from the skin and mucosae of macaques, support the repli­cation of SIV. AIDS Res Hum Retroviruses 13:819-827, 1997. PMID: 9197376 DOI: http://dx.doi.org/10.1089/aid.1997.13.819

Powderly WG, Robinson K, Keath EJ. Molecular epidemiologyof recurrent oral candidiasis in human immunodeficiency virus­-positive patients: evidence for two patterns of recurrence. J InfectDis 168:463-466, 1993. PMID: 8335986

Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Van Dyke T, Banchereau J. Lipopolysaccharides from distinct pathogens induce di­fferent classes of immune responses in vivo. J Immunol 167:5067-5076, 2001.

Pulendran B, Smith JL, Caspary G et al. Distinct dendritic cellsubsets differentially regulate the class of immune response in vivo.Proc Natl Acad Sci USA 96:1036-1041, 1999. DOI: http://dx.doi.org/10.1073/pnas.96.3.1036

Qureshi MN, Barr CE, Seshamma T, Reidy J, Pomerantz RJ,Bagasra O. Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons. J Infect Dis 171:190-193, 1995. DOI: http://dx.doi.org/10.1093/infdis/171.1.190

Rabeneck L and Laine L. Esophageal candidiasis in patients infec­ted with the immunodeficiency virus. A decision analysis to assesscost-effectiveness of alternative management strategies. Arch InternMed 154:2705-2710, 1994. DOI: http://dx.doi.org/10.1001/archinte.1994.00420230096011

Radeke HH, von Wenckstern H, Stoidtner K, Sauer B, Hammer S, Kleuser B. Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. J Immunol174:2778-2786, 2005. PMID: 15728487

Ramírez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya­-Saavedra G, González-Ramírez I, Ponce-de-León S. The changingclinical spectrum of human immunodeficiency virus (HIV)-relatedoral lesions in 1,000 consecutive patients: A 12-year study in a referral center in Mexico. Medicine (Baltimore) 82:39-50, 2003.

Ramírez-Amador V, Ponce-de-León S, Anaya-Saavedra G, CrabtreeRamírez B, Sierra-Madero J. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study inMexico City. Clin Infec Dis 45:925-932, 2007.

Rayhan R, Xu L, Santarpia RP 3rd, Tylenda CA, Pollock JJ. Antifungal activities of salivary histidine-rich polypeptides against Candida albi­cans and other oral yeast isolates. Oral Microbiol Immunol 7:51-52, 1992. PMID: 1528625 DOI: http://dx.doi.org/10.1111/j.1399-302X.1992.tb00020.x

Redding SW, Pfaller MA, Messer SA et al. Variations in fluconazolesusceptibility and DNA subtyping of multiple Candida albicans co­lonies from patients with AIDS and oral candidiasis suffering one ormore episodes of infection. J Clin Microbiol 35:1761-1765, 1997.PMID: 9196188

Reef SE and Mayer KH. Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues andpriorities. Clin Infect Dis 21S:99-102, 1995.

Reibel J, Dabelsteen E, Kenrad B, Buschard K. Pattern of distributionof T lymphocytes, Langerhans cells and HLA-DR bearing cells in normal human oral mucosa. Scand J Dent Res 93:513-521, 1985. PMID: 2937133DOI: http://dx.doi.org/10.1111/j.1600-0722.1985.tb01349.x

Reichart PA, Samaranayake LP, Philipsen HP. Pathology and clini­cal correlates in oral candidiasis and its variants: a review. Oral Dis6:85-91, 2000. PMID: 10702784

Reichart PA, Philipsen HP, Schmidt-Westhausen A, Samaranayake LP. Pseudomembranous oral candidiasis in HIV infection: ultrastructural findings. J Oral Pathol Med 24:276-281, 1995. PMID: 7562665

Reichart PA, Schmidt-Westhausen A, Samaranayake LP, Philipsen HP. Candida-associated palatal papillary hyperplasia in HIV infection. JOral Pathol Med 23:403-405, 1994. PMID: 7823300 DOI: http://dx.doi.org/10.1111/j.1600-0714.1994.tb00085.x

Reichart PA, Weigel D, Schmidt-Westhausen A, Pohle HD. Exfolia­tive cheilitis (EC) in AIDS: association with Candida infection. J Oral Pathol Med 26:290-293, 1997. PMID: 9234190

Reid DM, Gow NA, Brown GD. Pattern recognition: recent insights from Dectin-1. Curr Opin Immunol 21:30-37, 2009.

Rhodus NL, Bloomquist C, Liljemark W, Bereuter J. Prevalence,density, and manifestations of oral Candida albicans in patients withSjögren´s syndrome. J Otolaryngol 26:300-305, 1997.

Ripeau JS, Fiorillo M, Aumont F, Belhumeur P, de Repentigny L.Evidence for differential expression of Candida albicans virulence ge­nes during oral infection in intact and human immunodeficiency virus type 1-transgenic mice. J Infect Dis 185:1094-1102, 2002. PMID:11930319 DOI: http://dx.doi.org/10.1086/340035

Rissoan MC, Soumelis V, Kadowaki N et al. Reciprocal control of Thelper cell and dendritic cell differentiation. Science 283:1124-1125, 1999. DOI: http://dx.doi.org/10.1126/science.283.5405.1183

Robinson PG, Challacombe SJ, Sheiham A, Zakrzewska JM.Is erythematous candidiasis associated with advanced HIVdisease? Oral Dis 3S:116-118, 1997. DOI: http://dx.doi.org/10.1111/j.1601-0825.1997.tb00339.x

Robinson MJ, Osorio F, Rosas M et al. Dectin-2 is a Syk-coupledpattern recognition receptor crucial for Th17 responses to fungalinfection. J Exp Med 206:2037-2051, 2009. DOI: http://dx.doi.org/10.1084/jem.20082818

Romagnoli P, Pimpinelli N, Mori M, Reichart PA, Eversole LR,Ficarra G. Immunocompetent cells in oral candidiasis of HIV-infected patients: an immunohistochemical and electron microscopical study. Oral Dis 3:99-105, 1997. PMID: 9467350

Romani N, Gruner S, Brang D et al. Proliferating dendritic cell pro­genitors in human blood. J Exp Med 180:83-93, 1994. DOI: http://dx.doi.org/10.1084/jem.180.1.83

Royce RA, Luckmann RS, Fusaro RE, Winkelstein W, Jr.The natural history of HIV-1 infection: staging classifications of disease. AIDS5:355-364, 1991. PMID: 1676278

Rutherford GW, Sangani PR, Kennedy GE. Three- or four- versustwo-drug antiretroviral maintenance regimens for HIV infection.Cochrane Database Syst Rev 4:CD002037, 2003. PMID: 14583945

Samaranayake LP and Holmstrup P. Oral candidiasis and hu­man immunodeficiency virus infection. J Oral Pathol Med18:554-564, 1989. PMID: 2695620 DOI: http://dx.doi.org/10.1111/j.1600-0714.1989.tb01552.x

Samaranayake LP, Hughes A, Weetman DA, MacFarlane TW. Growth and acid production of Candida species in human saliva supplemen­ted with glucose. J Oral Pathol 15:251-254, 1986. PMID: 3091791DOI: http://dx.doi.org/10.1111/j.1600-0714.1986.tb00617.x

Samaranayake YH, Samaranayake LP, Pow EH, Beena VT, Yeung KW. Antifungal effects of lysozyme and lactoferrin against geneticallysimilar, sequential Candida albicans isolates from a human immu­nodeficiency virus-infected southern Chinese cohort. J Clin Micro­biol 39:3296-3302, 2001. PMID: 11526166 DOI: http://dx.doi.org/10.1128/JCM.39.9.3296-3302.2001

Sangeorzan JA, Bradley SF, He X et al. Epidemiology of oral candi­diasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 97:339-346, 1994.PMID: 7942935

Sansonetti PJ. The innate signaling of dangers and the dangers ofinnate signaling. Nat Immunol 7:1237-1242, 2006. PMID: 17110939 DOI: http://dx.doi.org/10.1038/ni1420

Schaller M, Mailhammer R, Korting HC. Cytokine expression indu­ced by Candida albicans in a model of cutaneous candidosis based onreconstituted human epidermis. J Med Microbiol 51:672-676, 2002.

Schmidt-Westhausen AM, Priepke F, Bergmann FJ, Reichart PA. De­cline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 29:336-341, 2000. PMID: 10947250 DOI: http://dx.doi.org/10.1034/j.1600-0714.2000.290708.x

Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480-483, 1998. PMID: 9624005 DOI:http://dx.doi.org/10.1038/31002

Schorling SR, Kortinga HC, Froschb M, Mühlschegel FA. The role of Candida dubliniensis in oral candidiasis in human immunodeficiencyvirus-infected individuals. Crit Rev Microbiol 26:59-68, 2000.DOI: http://dx.doi.org/10.1080/10408410091154183

Schuman P, Sobel JD, Ohmit SE et al. Mucosal candidal colonization and candidiasis in women with or at risk for human immunodefi­ciency virus infection. HIV Epidemiology Research Study (HERBS)Group. Clin Infect Dis 27:1161-1167, 1998. DOI: http://dx.doi.org/10.1086/514979

Segal AW. How neutrophils kill microbes. Ann Rev Immunol23:197-223, 2005. DOI: http://dx.doi.org/10.1146/annurev.immunol.23.021704.115653

Séguier S, Godeau G, Brousse N. Immunohistological and mor­phometric analysis of intra-epithelial lymphocytes and Langerhanscells in healthy and diseased human gingival tissues. Arch Oral Biol45:441-452, 2000. PMID: 10775673

Séguier S, Godeau G, Leborgne M, Pivert G, Brousse N. Quantitative morphological analysis of Langerhans cells in healthy and diseasedhuman gingiva. Arch Oral Biol 45:1073-1081, 2000. PMID: 11084147

Selik RM, Starcher ET, Curran JW. Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends. AIDS 1:175-182, 1987. PMID: 2831912

Sepkowitz KA. Effect of HAART on natural history of AIDS-related opportunistic disorders. Lancet 351:228-230, 1998. PMID: 9457088 DOI: http://dx.doi.org/10.1016/S0140-6736(05)78279-9

Sherwood J, Gow NA, Gooday GW, Gregory DW, Marshall D. Con­tact sensing in Candida albicans: a possible aid to epithelial penetration. J Med Vet Mycol 30:461-469, 1992.

Shiboski CH. Epidemiology of HIV-related oral manifestations inwomen: a review. Oral Dis 3S:18-27, 1997.

Shortman K and Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2:151-161, 2002. PMID: 11913066 DOI: http://dx.doi.org/10.1038/nri746

Soukka T, Tenovuo J, Lenander-Lumikari M. Fungicidal effectof human lactoferrin against Candida albicans. FEMS MicrobiolLett 69:223-228, 1992. PMID: 1555756 DOI: http://dx.doi.org/10.1111/j.1574-6968.1992.tb05156.x

Steele C and Fidel PL, Jr. Cytokine and chemokine production byhuman oral and vaginal epithelial cells in response to Candida albicans. Infect Immun 70:577-583, 2002. DOI: http://dx.doi.org/10.1128/IAI.70.2.577-583.2002

Steele C, Leigh J, Swoboda R, Ozenci H, Fidel PL, Jr. Potentialrole for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells. Infect Immun 69:7091-1099, 2001. DOI: http://dx.doi.org/10.1128/IAI.69.11.7091-7099.2001

Steidley KE, Thompson SH, McQuade MJ, Strong SL, Scheidt MJ,Van Dyke TE. A comparison of T4:T8 lymphocyte ratio in the pe­riodontal lesion of healthy and HIV-positive patients. J Periodontol63:753-756, 1992. PMID: 1361945

Stein DS, Korvick JA, Vermund SH. CD4+ lymphocyte cell enumera­tion for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis 165:352-363, 1992. PMID: 1346152

Steinhoff M, Brzoska T, Luger TA. Keratinocytes in epidermal im­mune responses. Curr Opin Allergy Clin Immunol 1:469-476, 2001. PMID: 11964729 DOI: http://dx.doi.org/10.1097/00130832-200110000-00014

Steinman RM, Adams JC, Cohn ZA. Identification of a novel celltype in peripheral lymphoid organs of mice. IV. Identification anddistribution in mouse spleen. J Exp Med 141:804-820, 1975.

Steinman RM and Cohn ZA. Identification of a novel cell type inperipheral lymphoid organs of mice. I. Morphology, quantitation,tissue distribution. J Exp Med 137:1142-1162, 1973. DOI: http://dx.doi.org/10.1084/jem.137.5.1142

Steinman RM and Cohn ZA. Identification of a novel cell type inperipheral lymphoid organs of mice. II. Functional properties in vitro. J Exp Med 139:380-397, 1974. DOI: http://dx.doi.org/10.1084/jem.139.2.380

Steinman RM, Kaplan G, Witmer MD, Cohn ZA. Identification of a novelcell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J ExpMed 149:1-16, 1979. DOI: http://dx.doi.org/10.1084/jem.149.1.1

Downloads

Published

2016-01-12

How to Cite

1.
Santo MD. Reconstitution of the immunological defence and Candida albicans infection in oral mucosa of HIV+ patients under HAART. J Oral Diagn [Internet]. 2016 Jan. 12 [cited 2024 Sep. 19];1:61-8. Available from: https://jordi.com.br/revista/article/view/232

Issue

Section

Review Article